{
  "docId": "019de070-d3cd-70da-8da9-11fac56c0e6a",
  "docSlug": "a10c554cbe4a4cf1ea91fc4610f64010",
  "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 27 slides",
  "authorId": "neurobo-pharmaceuticals",
  "authorName": "NeuroBo Pharmaceuticals",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 13,
  "pageCount": 27,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 3,
  "notes": "Includes a timeline diagram of the experimental procedure and a bar chart showing fold change in viral genome equivalents.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-d3cd-70da-8da9-11fac56c0e6a/13",
  "deckHref": "/decks/019de070-d3cd-70da-8da9-11fac56c0e6a",
  "deckJsonHref": "/decks/019de070-d3cd-70da-8da9-11fac56c0e6a.json",
  "deckAnchorHref": "/decks/019de070-d3cd-70da-8da9-11fac56c0e6a#slide-13",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.15,
        "x": 0.78,
        "y": 0.45
      },
      "kind": "chart",
      "text": "Bar chart showing fold change (GE/ml) for veh, spd, and nic treatments.",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "35485a85-dec5-40fb-a9ff-dd654cd3de01",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.7,
        "x": 0.05,
        "y": 0.062
      },
      "kind": "diagram",
      "text": "Experimental timeline showing pre-treatment, drug washout, infection, replication, and analysis phases.",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b8f87de5-e2ec-498e-9c5e-2b51fdec0d70",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.7,
        "x": 0.05,
        "y": 0.035
      },
      "kind": "list",
      "text": "VeroFM cells were pre-treated with spermidine (spd, 100 µM), niclosamide (nic, 5 µM) or control (veh) 24 h prior to infection with SARS-CoV-2. Spermidine is a natural enhancer of autophagy to protect the body. 24 h after infection, viral replication was assessed (normalized to control).",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dceeb18a-c937-490d-84a6-3c948105a39e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.01,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Gassen et al., 2020, Preprint from bioRxiv, doi: 10.1101/2020.04.15.997254",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c4921cf7-6af3-4f6a-a928-fedf2f24a310",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "title",
      "text": "Pre-treating cells with niclosamide reduces viral replication by ~70%",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "025cc933-23e4-4e5f-8aac-313e4db9e82f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.45,
        "x": 0.05,
        "y": 0.03
      },
      "kind": "title",
      "text": "Niclosamide as COVID-19 Prophylaxis",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "036cf486-f209-4a6a-b3bf-fd7a8618166b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Before-After-Bridge",
      "slug": "before-after-bridge",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "a2d3df05-e112-46f6-88f6-1166d3dfea6f",
      "evidence": "Pre-treating cells with niclosamide reduces viral replication by ~70%",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 13,
      "from": 10,
      "beatId": "5169c810-3b0c-4740-947f-27f8b9f7e416",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "Slides 10-13 present ANA001 as a solution, including its mechanism of action and efficacy data.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}